CSIMarket
 


Mei Pharma Inc   (MEIP)
Other Ticker:  
 
 

MEIP's Capital Expenditures Growth by Quarter and Year

Mei Pharma Inc 's Capital Expenditures results by quarter and year




MEIP Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - 0.04 0.31 0.01
III Quarter March - 0.01 0.11 0.00
II Quarter December - 0.00 0.05 0.06
I Quarter September 0.00 0.06 0.01 0.64
FY   0.00 0.11 0.48 0.71



MEIP Capital Expenditures first quarter 2024 Y/Y Growth Comment
Mei Pharma Inc in the first quarter 2024 recorded Capital Expenditures of $ 0.00 millions.

Looking into first quarter 2024 results within Major Pharmaceutical Preparations industry 40 other companies have achieved higher Capital Expenditures growth. While Mei Pharma Inc ' s Capital Expenditures no change of % ranks overall at the positon no. 857 in the first quarter 2024.




MEIP Capital Expenditures ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - -87.1 % 3000 % -90.91 %
III Quarter March - -90.91 % - -
II Quarter December - - -16.67 % -
I Quarter September - 500 % -98.44 % 6300 %
FY   - -77.08 % -32.39 % -21.11 %

Financial Statements
Mei Pharma Inc 's first quarter 2024 Capital Expenditures $ 0.00 millions MEIP's Income Statement
Mei Pharma Inc 's first quarter 2023 Capital Expenditures $ 0.06 millions Quarterly MEIP's Income Statement
New: More MEIP's historic Capital Expenditures Growth >>


MEIP Capital Expenditures (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - 300 % 181.82 % -
III Quarter March - - 120 % -
II Quarter December - - 400 % -90.63 %
I Quarter September - -80.65 % 0 % 481.82 %
FY (Year on Year)   - -77.08 % -32.39 % -21.11 %




Capital Expenditures first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #41
Healthcare Sector #115
Overall #857

Capital Expenditures Y/Y Growth Statistics
High Average Low
31680 % 31680 % 31680 %
(Dec 31 2020)  
Capital Expenditures first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #41
Healthcare Sector #115
Overall #857
Capital Expenditures Y/Y Growth Statistics
High Average Low
31680 % 31680 % 31680 %
(Dec 31 2020)  

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Mei Pharma Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MEIP's I. Quarter Q/Q Capital Expenditures Comment
Recent accomplishment of 0.00 millions by Mei Pharma Inc look even more unfavourable considering the 0.04 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Mei Pharma Inc achieved highest sequential Capital Expenditures growth. While Mei Pharma Inc 's Capital Expenditures growth quarter on quarter, overall rank is .


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MEIP's I. Quarter Q/Q Capital Expenditures Comment
Recent results of 0.00 millions by Mei Pharma Inc look even more unfavourable compare to the 0.04 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Mei Pharma Inc achieved highest sequential Capital Expenditures growth. While Mei Pharma Inc 's Capital Expenditures growth quarter on quarter, overall rank is .


Mei Pharma Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.41 $ 0.53
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - -23.78 % 11.48 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1132 # 173 # 136 # 219 # 119




Cumulative Capital Expenditures growth Comment
Mei Pharma Inc realized trailing twelve months Capital Expenditures of $ 0 millions, in the Sep 30 2023, compare to Capital Expenditures of $ 1 millions a year ago.

Mei Pharma Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
31680 %
31680 %
31680 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 58
Sector # 153
S&P 500 # 1132
Cumulative Capital Expenditures growth Comment
Mei Pharma Inc realized trailing twelve months Capital Expenditures of $ 0 millions, in the Sep 30 2023, compare to Capital Expenditures of $ 1 millions a year ago.

Mei Pharma Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
31680 %
31680 %
31680 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 58
Sector # 153
S&P 500 # 1132




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
MEIP's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for MEIP's Competitors
Capital Expenditures Growth for Mei Pharma Inc 's Suppliers
Capital Expenditures Growth for MEIP's Customers

You may also want to know
MEIP's Annual Growth Rates MEIP's Profitability Ratios MEIP's Asset Turnover Ratio MEIP's Dividend Growth
MEIP's Roe MEIP's Valuation Ratios MEIP's Financial Strength Ratios MEIP's Dividend Payout Ratio
MEIP's Roa MEIP's Inventory Turnover Ratio MEIP's Growth Rates MEIP's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Encompass Health Corporation-0.54%$ -0.542 millions
Myriad Genetics Inc -1.13%$ -1.130 millions
Opgen inc -1.22%$ -1.220 millions
Avantor Inc -3.33%$ -3.333 millions
United Therapeutics Corporation-4.51%$ -4.506 millions
Enanta Pharmaceuticals Inc-4.80%$ -4.802 millions
Davita Inc -5.46%$ -5.463 millions
Science 37 Holdings Inc -5.63%$ -5.630 millions
Cutera Inc -5.71%$ -5.708 millions
Zoetis Inc -5.84%$ -5.844 millions
U S Physical Therapy Inc-6.25%$ -6.248 millions
Generation Bio Co -6.30%$ -6.298 millions
Ngm Biopharmaceuticals Inc -6.45%$ -6.452 millions
Becton Dickinson And Company-6.67%$ -6.667 millions
3m Company-6.90%$ -6.897 millions
Apyx Medical Corporation-7.45%$ -7.447 millions
Edwards Lifesciences Corporation-7.68%$ -7.679 millions
Viatris Inc -7.70%$ -7.700 millions
Luna Innovations Inc-8.23%$ -8.232 millions
Nevro Corp -8.38%$ -8.377 millions
Shockwave Medical Inc -8.65%$ -8.649 millions
Sonendo Inc -8.86%$ -8.861 millions
Charles River Laboratories International inc -8.90%$ -8.904 millions
Nautilus Biotechnology Inc -9.24%$ -9.242 millions
Harvard Bioscience Inc-9.28%$ -9.276 millions
Fulgent Genetics Inc -9.42%$ -9.420 millions
Idexx Laboratories Inc-9.53%$ -9.529 millions
Sage Therapeutics Inc -9.89%$ -9.890 millions
Caredx Inc -10.40%$ -10.400 millions
Quest Diagnostics Inc-11.02%$ -11.017 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com